Table 1.
Basic Characteristics of included patients
| Diagnosis | Disease severity | ||||
|---|---|---|---|---|---|
| Suspected (n = 22) |
Laboratory-confirmed (n = 147) |
Non-severe (n = 122) | Severe (n = 25) |
P value# | |
| Age, median (IQR), yrs | 51 (34–56) | 44 (33–50) | 43 (31–49) | 50 (43–64) | 0.005 |
| Age groups, No./total (%) | |||||
| < 15 yrs | 1/22 (4.6) | 1/147 (0.7) | 1/122 (0.8) | 0/25 (0.0) | 0.29* |
| 15–44 yrs | 8/22 (36.4) | 76/147 (51.7) | 67/122 (54.9) | 9/25 (36.0) | ·· |
| 45–64 yrs | 10/22 (45.4) | 54/147 (36·7) | 42/122 (34·4) | 12/25 (48·0) | ·· |
| ≥ 65 yrs | 3/22 (13·6) | 16/147 (10·9) | 12/122 (9·8) | 4/25 (16·0) | ·· |
| Female sex, No./total (%) | 7/22 (31·8) | 57/147 (38·8) | 51/122 (41·8) | 6/25 (24·0) | 0·096 |
| Ethnic, No./total (%) | ·· | ·· | ·· | ·· | 0·79 |
| Tibetan | 0/22 (0·0) | 10/147 (6·8) | 8/122 (6·6) | 2/25 (8·0) | ·· |
| Non-Tibetan | 22/22 (100·0) | 137/147 (93·2) | 114/122 (93·4) | 23/25 (92·0) | ·· |
| Exposure history within 14 days, No./total (%) | |||||
| Local residents of Wuhan or recently been to Wuhan | 4/13 (30·8) | 82/134 (61·2) | 66/110 (60·0) | 16/24 (66·7) | 0·54 |
| Non local: contacted with people from Wuhan | 4/12 (33·3) | 23/119 (19·3) | 21/99 (21·2) | 2/20 (10·0) | 0·42 |
| Health-care workers | 0/14 (0·0) | 2/132 (1·5) | 2/111 (1·8) | 0/21 (0·0) | > 0·99* |
| Comorbidities, No./total (%) | 6/21 (28·6) | 47/146 (32·2) | 32/122 (26·2) | 15/24 (62·5) | 0·0010 |
| Pulmonary diseases | 2/21 (9·5) | 11/146 (7·5) | 5/122 (4·1) | 6/24 (25) | 0·0020 |
| Chronic obstructive pulmonary diseases | 2/21 (9·5) | 6/146 (4·1) | 3/122 (2·5) | 3/24 (12·5) | 0·056* |
| Asthma | 1/21 (4·8) | 1/146 (0·7) | 0/122 (0·0) | 1/24 (4·2) | 0·16* |
| Lung tumor | 0/21 (0·0) | 1/146 (0·7) | 1/122 (0·8) | 0/24 (0·0) | > 0·99* |
| Tuberculosis | 0/21 (0·0) | 3/146 (2·1) | 1/122 (0·8) | 2/24 (8·3) | 0·070* |
| Other comorbidities | 6/21 (28·6) | 43/146 (29·5) | 31/122 (25·4) | 12/24 (50·0) | 0·030 |
| Hypertension | 3/21 (14·3) | 19/146 (13·0) | 11/122 (9·0) | 8/24 (33·3) | 0·0040 |
| Diabetes | 2/21 (9·5) | 10/146 (6·8) | 6/122 (4·9) | 4/24 (16·7) | 0·10 |
| Heart and cardiovascular diseases | 2/21 (9·5) | 9/146 (6·2) | 5/122 (4·1) | 4/24 (16·7) | 0·061 |
| Chronic kidney diseases | 1/21 (4·8) | 4/146 (2·7) | 2/122 (1·6) | 2/24 (8·3) | 0·13* |
| Chronic liver diseases | 1/21 (4·8) | 5/146 (3·4) | 4/122 (3·3) | 1/24 (4·2) | > 0·99* |
Abbreviations: IQR Interquartile range
* The P-value was derived from Fisher’s exact test, two-sided
# P-value for the comparison between severe cases versus non- severe infected patients